c-Met signaling is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2025-09-12. Numbers and descriptions here follow the published literature rather than marketing material.
Most published work on dihexa consists of preclinical studies using cell cultures or rodents. Reports have described effects on synaptic connectivity and performance on cognitive tasks in some animal models. These findings are generally presented as preliminary and require independent replication. Study designs, doses, and outcome measures vary across experiments, which complicates direct comparison. No large controlled human trials have established efficacy or safety for any medical use. At present, the evidence base is limited.
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Lyophilized dihexa is typically stored as a dry powder at or below minus twenty degrees Celsius. Cooler temperatures slow degradation, and desiccant protection limits moisture uptake. Repeated temperature cycling can accelerate breakdown, so aliquoting before storage is common in laboratory practice. Solutions are generally less stable than dry powder and are often kept cold, protected from light, and used within a defined period. Specific stability data for dihexa are limited, and handling recommendations often follow general peptide guidelines rather than compound-specific studies.
Identity and purity are usually assessed with reverse-phase high-performance liquid chromatography and mass spectrometry. These methods can separate related impurities and confirm molecular mass, but they do not by themselves establish biological activity. Certificate of analysis documents may report purity as a percentage by area, yet the exact meaning can vary between laboratories. Independent testing can check for residual solvents, counterions, or microbial contamination when relevant. For research use, matching analytical records to a specific lot helps trace experimental variability.
| Property | Value | Notes |
|---|---|---|
| Development status | Preclinical research | No approved therapeutic indication has been established. |
| Human data | Limited or absent | Published controlled trials in people are not available. |
| Regulatory classification | Varies by country | Often treated as a research chemical rather than a medicine. |
| Common supply form | Lyophilized powder | Sold for laboratory use, not for human consumption. |
| Quality checks | Certificate of analysis; HPLC; mass spectrometry | Used to verify identity and purity in research settings. |
The proposed mechanism of dihexa centers on activation of the hepatocyte growth factor receptor, also called c-Met. Some studies suggest it acts as a mimetic of hepatocyte growth factor, promoting signaling pathways involved in synapse formation. Other work has explored interactions with angiotensin IV pathways, but the exact binding targets remain uncertain. Laboratory findings come mainly from cell cultures and animal models. Whether these mechanisms operate similarly in humans is an open question. Researchers have not established a single, universally accepted mechanism of action.
Identity and purity of dihexa samples are typically assessed with high-performance liquid chromatography and mass spectrometry. These methods can confirm molecular mass and estimate the presence of impurities. However, a certificate of analysis from a supplier is not a guarantee of independent testing. Researchers often require in-house verification before using a peptide in experiments. For solid samples, appearance, solubility, and chromatographic profile provide additional checks. Nuclear magnetic resonance may be used for structural confirmation when available.
Laboratory characterization of dihexa typically relies on reverse-phase high-performance liquid chromatography for purity and mass spectrometry for identity. These methods are standard for synthetic peptides and help distinguish the target compound from related impurities or degradation products. Because dihexa is a small peptide-like molecule, it may be susceptible to hydrolysis under certain conditions. Storage recommendations generally emphasize low temperature, dryness, and protection from light. Analytical certificates from suppliers vary in detail, so independent verification can be important for research use.
Reported effects of dihexa are often described in terms of synaptogenesis, a process by which neurons form new synaptic connections. This concept is biologically plausible but difficult to measure directly in living humans. Animal behavioral tests can suggest memory or learning changes, yet such tests have limitations and may not translate to people. The literature includes conflicting or incomplete findings, and some studies are small. As a result, the mechanism remains a subject of investigation rather than a settled explanation.
Dihexa is a synthetic peptide with the chemical name N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide, and it is structurally related to angiotensin IV, a naturally occurring peptide fragment. Researchers developed it as a modified analog intended to alter stability and activity relative to the parent peptide. Its short sequence and fatty acid chain distinguish it from many endogenous peptides, and published studies often describe it under the abbreviation dihexa. The compound is classified as a laboratory compound rather than an approved therapeutic in most jurisdictions.
Early laboratory work focused on its effects on synaptic connectivity and neuronal signaling. In cell and animal models, dihexa has been reported to promote the formation of new synapses, a process called synaptogenesis. These findings have generated interest in cognitive research, but the evidence base remains mostly preclinical. Human clinical trials with clear safety and efficacy endpoints are limited or absent in the public literature. Whether these effects translate to humans is an open question.
The proposed mechanism involves interaction with the hepatocyte growth factor (HGF) system and its receptor, c-Met. Dihexa is described in some studies as an HGF mimetic, meaning it may mimic or enhance HGF-mediated signaling. Activation of c-Met can influence cell growth, survival, and cytoskeletal remodeling, pathways that intersect with synaptic plasticity. However, the precise binding targets and downstream events for dihexa are not fully established, and alternative mechanisms have been suggested.
=== 19 April === South Korean President Yoon Suk-yeol, announced that they would send military aid to Ukraine, if Russia carries out any more large-scale attacks against civilians in Ukraine. Dmitry Medvedev, Deputy Secretary of the Security Council of Russia and former Russian President, responded by saying that if South Korea were to send military aid to Ukraine, Russia would respond by sending military aid to the Democratic People's Republic of Korea on a "...quid pro quo" basis. President Yoon drew comparisons between the war in Ukraine and the Korea War of 1950–53 and how the international community supported South Korea. Several foreign volunteers were killed by Russian forces in Bakhmut, including: Dmitry Petrov from Russia; Finbar Cafferkey from Ireland; and Cooper “Harris” Andrews from the United States. The death of Cafferkey caused a strain in Ireland–Russia relations.
=== Regulatory macrophages === Glucocorticoids can contribute to the development of regulatory macrophages. These macrophages produce Interleukin 10 and inhibit immune system response (See below for Effect on cancer). Tumor-associated macrophages may contain a large population of regulatory macrophages.
== Historical understanding == Historically, there has been much dispute over whether such a thing as a vacuum can exist. Ancient Greek philosophers debated the existence of a vacuum, or void, in the context of atomism, which posited void and atom as the fundamental explanatory elements of physics. Lucretius argued for the existence of vacuum in the first century BC and Hero of Alexandria tried unsuccessfully to create an artificial vacuum in the first century AD. Following Plato, however, even the abstract concept of a featureless void faced considerable skepticism: it could not be apprehended by the senses, it could not, itself, provide additional explanatory power beyond the physical volume with which it was commensurate and, by definition, it was quite literally nothing at all, which cannot rightly be said to exist. Aristotle believed that no void could occur naturally, because the denser surrounding material continuum would immediately fill any incipient rarity that might give rise to a void. In his Physics, book IV, Aristotle offered numerous arguments against the void: for example, that motion through a medium which offered no impediment could continue ad infinitum, there being no reason that something would come to rest anywhere in particular. In the medieval Muslim world, the physicist and Islamic scholar Al-Farabi wrote a treatise rejecting the existence of the vacuum in the 10th century. He concluded that air's volume can expand to fill available space, and therefore the concept of a perfect vacuum was incoherent.
Sources: en.wikipedia.org
At microwave frequencies, the first, imperfect invisibility cloak was realized in 2006. From the standpoint of governing equations, contemporary researchers can classify the realm of metamaterials into three primary branches: Electromagnetic/Optical wave metamaterials, other wave metamaterials, and diffusion metamaterials. These branches are characterized by their respective governing equations, which include Maxwell's equations (a wave equation describing transverse waves), other wave equations (for longitudinal and transverse waves), and diffusion equations (pertaining to diffusion processes). Crafted to govern a range of diffusion activities, diffusion metamaterials prioritize diffusion length as their central metric. This crucial parameter experiences temporal fluctuations while remaining immune to frequency variations. In contrast, wave metamaterials, designed to adjust various wave propagation paths, consider the wavelength of incoming waves as their essential metric. This wavelength remains constant over time, though it adjusts with frequency alterations. Fundamentally, the key metrics for diffusion and wave metamaterials present a stark divergence, underscoring a distinct complementary relationship between them. For comprehensive information, refer to Section I.B, "Evolution of metamaterial physics," in Ref.
Tranexamic acid is a medication used to treat or prevent excessive blood loss from major trauma, postpartum bleeding, surgery, tooth removal, nosebleeds, and heavy menstruation. It is also used for hereditary angioedema. It is taken either by mouth, injection into a vein, or by intramuscular injection. Tranexamic acid is a synthetic analog of the amino acid lysine. It serves as an antifibrinolytic by reversibly binding four to five lysine receptor sites on plasminogen. This decreases the conversion of plasminogen to plasmin, preventing fibrin degradation and preserving the framework of fibrin's matrix structure. Tranexamic acid has roughly eight times the antifibrinolytic activity of an older analogue, ε-aminocaproic acid. Tranexamic acid also directly inhibits the activity of plasmin with weak potency (IC50 = 87 mM), and it can block the active-site of urokinase plasminogen activator (uPA) with high specificity (Ki = 2 mM), one of the highest among all the serine proteases. Side effects are rare; they include changes in color vision, seizures, blood clots, and allergic reactions. Tranexamic acid appears to be safe for use during pregnancy and breastfeeding. Tranexamic acid was first made in 1962 by Japanese researchers Shosuke and Utako Okamoto. It is on the World Health Organization's List of Essential Medicines. Tranexamic acid is available as a generic drug.
The Bryant Park Restoration Corporation was founded in 1980 by Dan Biederman, along with Andrew Heiskell, chairman of Time Inc. and the New York Public Library. The BPRC immediately brought significant changes to remake the park into a place that people wanted to visit, and instituted a rigorous program to clean the park, remove graffiti, and repair physical damage. The BPRC also created a private security staff to confront unlawful behavior. In addition, the BPRC started an outdoor concert series in the summers. By 1982, arrests had decreased significantly compared to two years prior. Another agency—the Bryant Park Management Corporation, composed of several nearby businesses—was tasked with maintaining the park, spending $525,000 per year to do so. NYC Parks spent an additional $250,000 a year on maintenance, the same amount as when the city had sole control over the park's management. In 1983, HBO's president, Frank Biondi, gave Heiskell a $100,000 check just before the company moved into new headquarters at 1100 Avenue of the Americas, adjacent to the park. At the time, that was the largest donation toward Bryant Park by a private corporation.
Sources: en.wikipedia.org
However, it was hypothesized that even if the putative first RNA-dependent RNA-polymerases are estimated to be longer—the smallest reported up-to-date RNA-dependent polymerase ribozyme is 165 nucleotides long—they did not have to arise in one step. It is more plausible that ligation of smaller RNA chains performed by the first RNA ligases resulted in a longer chain with the desired catalytically active polymerase domain. Forty years after the publication of Manfred Eigen's primary work dedicated to hypercycles, Nilesh Vaidya and colleagues showed experimentally that ribozymes can form catalytic cycles and networks capable of expanding their sizes by incorporating new members. However, this is not a demonstration of a hypercycle in accordance with its definition, but an example of a collectively autocatalytic set. Earlier computer simulations showed that molecular networks can arise, evolve and be resistant to parasitic RNA branches. In their experiments, Vaidya et al. used an Azoarcus group I intron ribozyme that, when fragmented, has an ability to self-assemble by catalysing recombination reactions in an autocatalytic manner. They mutated the three-nucleotide-long sequences responsible for recognition of target sequences on the opposite end of the ribozyme (namely, Internal Guide Sequences or IGSs) as well as these target sequences. Some genotypes could introduce cooperation by recognizing target sequences of the other ribozymes, promoting their covalent binding, while other selfish genotypes were only able to self-assemble.
==== Micrococcus lysodeikticus ==== By the measurement of decrease in turbidity of M. lysodeikticus by incubating it with lysozyme, enzymatic activity can be evaluated. 7.5 μL of 0.1 - 1 mg/mL proteins is added to 200 μL of M. lysodeikticus at its optical density (OD) of 1.7 AU, and the mixture is measured at 450 nm periodically for reaction rate calculation. On the contrary to the result from glycol chitosan enzymatic activity, the increasing degree of PEGylation decreased the enzymatic activity. This difference in the trend of the enzymatic activity can be due to PEGylation to free lysine causing steric hindrance and subsequently preventing from forming enzyme-substrate complex in the case of reacting with macromolecule, such as M. lysodeikticus.
Presence of a pseudogap phase up to at least optimal doping. Different trends in the Uemura plot relating transition temperature to superfluid density. The inverse square of the London penetration depth appears to be proportional to the critical temperature for a large number of underdoped cuprate superconductors, but the constant of proportionality is different for hole- and electron-doped cuprates. The linear trend implies that the physics of these materials is strongly two-dimensional. Universal hourglass-shaped feature in the spin excitations of cuprates measured using inelastic neutron diffraction. Nernst effect evident in both the superconducting and pseudogap phases.
== Other uses == Kombucha culture, when dried, becomes a leather-like textile known as a microbial cellulose that can be molded onto forms to create seamless clothing. Using different broth media such as coffee, black tea, and green tea to grow the kombucha culture results in different textile colors, although the textile can also be dyed using other plant-based dyes. Different growth media and dyes also change the textile's feel and texture. Dried and processed SCOBY has been investigated as a leather substitute. Additionally, the SCOBY itself can be dried and eaten as a sweet or savory snack. Kombucha can be further used for bioleaching of yttrium oxide from waste fluorescent lamp phosphors.
Sources: en.wikipedia.org
Published human trials are lacking. Most evidence comes from laboratory and animal studies. Therefore, human benefits and risks are not established.
Rules differ by country and by how the product is labeled. Research chemicals are often sold for laboratory use only. Buyers should check local regulations before ordering.
Some animal studies have examined cognitive outcomes, which has led to online interest. These results do not prove cognitive enhancement in people. The term nootropic is not a regulatory category.
The lyophilized powder is commonly kept at -20 °C or lower, protected from moisture and light. Solutions may require colder storage and should avoid repeated freeze-thaw cycles. General peptide stability practices apply.